• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Sulbactam-durlobactam in combination with aztreonam and carbapenems against carbapenem-resistant : an assessment using the MIC-based broth disk elution.

作者信息

Koenig C, Nicolau D P, Asempa T E

机构信息

Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, Connecticut, USA.

Department of Intensive Care Medicine, University Hospital Hamburg-Eppendorf, Hamburg, Germany.

出版信息

J Clin Microbiol. 2025 Aug 13;63(8):e0070925. doi: 10.1128/jcm.00709-25. Epub 2025 Jul 24.

DOI:10.1128/jcm.00709-25
PMID:40704820
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12345227/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2696/12345227/06011f7906f0/jcm.00709-25.f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2696/12345227/06011f7906f0/jcm.00709-25.f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2696/12345227/06011f7906f0/jcm.00709-25.f001.jpg

相似文献

1
Sulbactam-durlobactam in combination with aztreonam and carbapenems against carbapenem-resistant : an assessment using the MIC-based broth disk elution.舒巴坦-度洛巴坦联合氨曲南及碳青霉烯类药物治疗耐碳青霉烯菌：基于最低抑菌浓度的肉汤纸片洗脱法评估
J Clin Microbiol. 2025 Aug 13;63(8):e0070925. doi: 10.1128/jcm.00709-25. Epub 2025 Jul 24.
2
Pharmacokinetic and pharmacodynamic evaluation of sulbactam-durlobactam in a critically ill patient on continuous venovenous hemofiltration infected with carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex.在一名接受持续静静脉血液滤过治疗、感染耐碳青霉烯鲍曼不动杆菌-醋酸钙不动杆菌复合体的重症患者中进行舒巴坦-度洛巴坦的药代动力学和药效学评估。
Pharmacotherapy. 2025 Jul;45(7):396-402. doi: 10.1002/phar.70027. Epub 2025 May 15.
3
Susceptibility toward cefiderocol and sulbactam-durlobactam in extensively drug-resistant detected from ICU admission screening in Hanoi, Vietnam, 2023.2023年在越南河内的重症监护病房入院筛查中检测到的广泛耐药菌对头孢地尔和舒巴坦-杜洛巴坦的敏感性。
Microbiol Spectr. 2025 Jul;13(7):e0083225. doi: 10.1128/spectrum.00832-25. Epub 2025 Jun 9.
4
Pharmacokinetics of Sulbactam/Durlobactam in a Patient With Acute Renal Failure, Severe Obesity, and Carbapenem-Resistant Acinetobacter baumannii Bacteremia: A Case Report.舒巴坦/度洛巴坦在一名急性肾衰竭、严重肥胖且耐碳青霉烯鲍曼不动杆菌血症患者中的药代动力学：病例报告
Pharmacotherapy. 2025 Aug;45(8):522-528. doi: 10.1002/phar.70042. Epub 2025 Jul 18.
5
Activity of ampicillin-sulbactam, sulbactam-durlobactam, and comparators against complex strains isolated from respiratory and bloodstream sources: results from ACNBio study.氨苄西林-舒巴坦、舒巴坦-度洛巴坦及对照药物对从呼吸道和血流来源分离出的复杂菌株的活性：ACNBio研究结果
Antimicrob Agents Chemother. 2025 Aug 6;69(8):e0037925. doi: 10.1128/aac.00379-25. Epub 2025 Jul 17.
6
Activity of Sulbactam-Durlobactam against Global Isolates of - Complex Collected from 2016 to 2021.舒巴坦-多利布坦对 2016 年至 2021 年收集的全球复杂 - 复合菌株的活性。
Antimicrob Agents Chemother. 2022 Sep 20;66(9):e0078122. doi: 10.1128/aac.00781-22. Epub 2022 Aug 25.
7
In vitro activity of sulbactam/durlobactam against global isolates of carbapenem-resistant Acinetobacter baumannii.多利培南/舒巴坦对全球碳青霉烯类耐药鲍曼不动杆菌分离株的体外活性。
J Antimicrob Chemother. 2020 Sep 1;75(9):2616-2621. doi: 10.1093/jac/dkaa208.
8
Successful Treatment of Carbapenem-Resistant Acinetobacter baumannii Meningitis With Sulbactam-Durlobactam.舒巴坦-多利培南成功治疗耐碳青霉烯鲍曼不动杆菌脑膜炎
Clin Infect Dis. 2024 Oct 15;79(4):819-825. doi: 10.1093/cid/ciae210.
9
Activity of Sulbactam-Durlobactam and Comparators Against a National Collection of Carbapenem-Resistant Isolates From Greece.舒巴坦-多利培南对来自希腊的全国碳青霉烯类耐药分离株的活性及与其他药物的比较。
Front Cell Infect Microbiol. 2022 Jan 20;11:814530. doi: 10.3389/fcimb.2021.814530. eCollection 2021.
10
Resistance to Sulbactam/Durlobactam: A Systematic Review.对舒巴坦/度洛巴坦的耐药性：一项系统评价。
Antibiotics (Basel). 2022 Dec 10;11(12):1793. doi: 10.3390/antibiotics11121793.

本文引用的文献

1
Activity of ampicillin-sulbactam, sulbactam-durlobactam, and comparators against complex strains isolated from respiratory and bloodstream sources: results from ACNBio study.氨苄西林-舒巴坦、舒巴坦-度洛巴坦及对照药物对从呼吸道和血流来源分离出的复杂菌株的活性：ACNBio研究结果
Antimicrob Agents Chemother. 2025 Aug 6;69(8):e0037925. doi: 10.1128/aac.00379-25. Epub 2025 Jul 17.
2
Unraveling sulbactam-durlobactam: insights into its role in combating infections caused by .解读舒巴坦-度洛巴坦：深入了解其在对抗由……引起的感染中的作用 。 （原文此处不完整）
Expert Rev Anti Infect Ther. 2025 Jan;23(1):67-78. doi: 10.1080/14787210.2024.2440018. Epub 2024 Dec 19.
3
Comparison of BD Phoenix and disk diffusion to broth microdilution for determining cefepime susceptibility among carbapenem-resistant Enterobacterales.
比较 BD Phoenix 与纸片扩散法和肉汤微量稀释法检测耐碳青霉烯类肠杆菌科细菌的头孢吡肟药敏结果。
J Clin Microbiol. 2024 Jun 12;62(6):e0152023. doi: 10.1128/jcm.01520-23. Epub 2024 May 7.
4
pharmacokinetics/pharmacodynamics of the β-lactamase inhibitor, durlobactam, in combination with sulbactam against complex.β-内酰胺酶抑制剂达芦那韦与舒巴坦联合对复杂感染的药代动力学/药效学。
Antimicrob Agents Chemother. 2024 Jan 10;68(1):e0031223. doi: 10.1128/aac.00312-23. Epub 2023 Dec 11.
5
Molecular drivers of resistance to sulbactam-durlobactam in contemporary clinical isolates of .当代临床分离株中对舒巴坦-多尼培南耐药的分子驱动因素。
Antimicrob Agents Chemother. 2023 Nov 15;67(11):e0066523. doi: 10.1128/aac.00665-23. Epub 2023 Oct 16.
6
Global Epidemiology and Mechanisms of Resistance of Acinetobacter baumannii-calcoaceticus Complex.鲍曼不动杆菌-醋酸钙不动杆菌复合体的全球流行病学和耐药机制。
Clin Infect Dis. 2023 May 1;76(Suppl 2):S166-S178. doi: 10.1093/cid/ciad109.
7
Multicenter Evaluation of an MIC-Based Aztreonam and Ceftazidime-Avibactam Broth Disk Elution Test.基于 MIC 的氨曲南和头孢他啶-阿维巴坦肉汤纸片洗脱试验的多中心评价。
J Clin Microbiol. 2023 May 23;61(5):e0164722. doi: 10.1128/jcm.01647-22. Epub 2023 Apr 18.
8
Resistance to Sulbactam/Durlobactam: A Systematic Review.对舒巴坦/度洛巴坦的耐药性：一项系统评价。
Antibiotics (Basel). 2022 Dec 10;11(12):1793. doi: 10.3390/antibiotics11121793.
9
Reversibility of Covalent, Broad-Spectrum Serine β-Lactamase Inhibition by the Diazabicyclooctenone ETX2514.二氮杂双环辛烯酮ETX2514对共价、广谱丝氨酸β-内酰胺酶抑制作用的可逆性
ACS Infect Dis. 2017 Nov 10;3(11):833-844. doi: 10.1021/acsinfecdis.7b00113. Epub 2017 Aug 28.
10
Molecular mechanisms of sulbactam antibacterial activity and resistance determinants in Acinetobacter baumannii.鲍曼不动杆菌中舒巴坦抗菌活性及耐药决定因素的分子机制
Antimicrob Agents Chemother. 2015 Mar;59(3):1680-9. doi: 10.1128/AAC.04808-14. Epub 2015 Jan 5.